- The hidden assumptions embedded in RFP design that narrow vendor capabilities
- How RFP structure shapes partnership dynamics and long-term outcomes
- Rethinking RFP strategy to access broader CRO expertise and innovation
- How real-world data (RWD) can be used to support clinical trials
- Illustrative example using UK electronic healthcare records
- Key MHRA guidance on RWD for clinical trials
- Regulatory requirements data quality
- Transparency reporting recommendations
- Tackling barriers that limit access and participation for under-represented patient groups.
- Ensuring cultural relevance, language accessibility and equitable site selection.
- Embedding PROs and patient insights to shape inclusive eligibility and trial procedures.
- Measuring what matters: evaluating the impact of patient-centred designs on recruitment and retention.
- What the new national target requires from sites and sponsors
- Meeting the NIHR’s new FPI targets: 30days for Rare, 60 days for all others
- Systemic challenges slowing UK clinical trial delivery
- Enablers: streamlined processes, capacity, and perforMaria Koufali mance management
- What success looks like for 2025–2026
